Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptors

Abstract Melatonin is a neurohormone that translates the circadian rhythm to the peripheral organs through a series of binding sites identified as G protein‐coupled receptors MT1 and MT2. Due to minute amounts of receptor proteins in target organs, the main tool of studies of the melatoninergic syst...

Full description

Saved in:
Bibliographic Details
Main Authors: Céline Legros (Author), Clémence Dupré (Author), Chantal Brasseur (Author), Anne Bonnaud (Author), Olivier Bruno (Author), Damien Valour (Author), Preety Shabajee (Author), Adeline Giganti (Author), Olivier Nosjean (Author), Terrence P. Kenakin (Author), Jean A. Boutin (Author)
Format: Book
Published: Wiley, 2020-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_08643ceb060e4077bb6c6bb5129fe136
042 |a dc 
100 1 0 |a Céline Legros  |e author 
700 1 0 |a Clémence Dupré  |e author 
700 1 0 |a Chantal Brasseur  |e author 
700 1 0 |a Anne Bonnaud  |e author 
700 1 0 |a Olivier Bruno  |e author 
700 1 0 |a Damien Valour  |e author 
700 1 0 |a Preety Shabajee  |e author 
700 1 0 |a Adeline Giganti  |e author 
700 1 0 |a Olivier Nosjean  |e author 
700 1 0 |a Terrence P. Kenakin  |e author 
700 1 0 |a Jean A. Boutin  |e author 
245 0 0 |a Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptors 
260 |b Wiley,   |c 2020-02-01T00:00:00Z. 
500 |a 2052-1707 
500 |a 10.1002/prp2.539 
520 |a Abstract Melatonin is a neurohormone that translates the circadian rhythm to the peripheral organs through a series of binding sites identified as G protein‐coupled receptors MT1 and MT2. Due to minute amounts of receptor proteins in target organs, the main tool of studies of the melatoninergic system is recombinant expression of the receptors in cellular hosts. Although a number of studies exist on these receptors, studies of several signaling pathways using a large number of melatoninergic compounds are rather limited. We chose to fill this gap to better describe a panel of compounds that have been only partially characterized in terms of functionality. First, we characterized HEK cells expressing MT1 or MT2, and several signaling routes with melatonin itself to validate the approach: GTPγS, cAMP production, internalization, β‐arrestin recruitment, and cell morphology changes (CellKey®). Second, we chose 21 compounds from our large melatoninergic chemical library and characterized them using this panel of signaling pathways. Notably, antagonists were infrequent, and their functionality depended largely on the pathway studied. This will permit redefining the availability of molecular tools that can be used to better understand the in situ activity and roles of these receptors. 
546 |a EN 
690 |a biased ligands 
690 |a melatonin 
690 |a melatonin receptors 
690 |a signaling pathways 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Pharmacology Research & Perspectives, Vol 8, Iss 1, Pp n/a-n/a (2020) 
787 0 |n https://doi.org/10.1002/prp2.539 
787 0 |n https://doaj.org/toc/2052-1707 
856 4 1 |u https://doaj.org/article/08643ceb060e4077bb6c6bb5129fe136  |z Connect to this object online.